WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 9901 Infant (under 12 months) mortality rate: 272
GDP / capita (US$): 2'4091 Child (under 5 years) mortality rate: 312

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 5'474  5'403  5'334  5'265  5'197  4'955  4'395  3'627 
Births 148  144  140  134  128  108  136  108 
Surviving infants 143  140  135  129  123  103  127  99 
Pop. less than 5 years 659  631  595  567  538  546  629  488 
Pop. less than 15 years 1'652  1'625  1'603  1'587  1'574  1'733  1'651  1'347 
Female 15-49 years 1'520  1'515  1'506  1'487  1'466  1'297  1'032  857 

Number of reported case

(Click for retrospective incidence data for Kyrgyzstan)
Diphtheria 15 
Japanese encephalitis
Measles 222  16  16  584 
Mumps 350  300  396  160  436  350 
Pertussis 62  77  109  224  45  34  237 
Polio*
Rubella 14  176 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kyrgyzstan)
Vaccine year result method % card seen                                                
BCG 2011  99  DHS   86.4  98  98  98  98  99  96 
DTP1 2011  97  DHS   86.4  97  97  99  98  100  99 
DTP3 2011  81  DHS   86.4  96  96  96  95  95  99 
HepB_BD          94  73  99  98  99  45 
HepB3 2011  81  DHS   86.4  96  96  96  96  97  44 
Hib3 2011  81  DHS   86.4  96  96  96 
JapEnc         
MCV 2011  97  DHS   86.4  98  97  99  99  99  98 
MCV2          98  98  98  99  97  96 
PCV1         
PCV3         
Pol3 2011  77  DHS   86.4  94  94  88  96  95  99 
Rota1         
Rota_last         
Rubella1          97  99 
TT2plus         
PAB         
VAD1          98  99 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kyrgyzstan)
BCG 98  98  98  98  99  96 
DTP1 96  97  99  98  99  99 
DTP3 96  96  96  95  95  99 
HepB3 96  96  96  96  97  44 
Hib3 96  96  96 
MCV 98  97  99  99  99  98 
PCV3
Pol3 94  94  88  96  95  99 
Rota_last

Number of districts in the country 40  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 2 years; Yes
DTwPHibHepB 2, 3.5, 5 months;
HepB birth; Yes
MMR 12 months; Yes
MR 6 years; Yes
OPV birth; 2, 3.5, 5 months; Yes
Td 11, 16, 26, 36, 46, 56 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2006-2012  2011-2016  2006-2010  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number   40  Yes  47  45  38  42 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  No  Yes         

System performance

Total number of districts in country number 40  40  42  52  52  52  52 
Nº districts with DTP3 coverage >=80% number 40  40      52  52 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100      100  100 
Nº districts with measles (MCV1) coverage >=95% number 40  38  42         
% of districts with MCV1 coverage >=95% From 0 to 100% 100  95  100         

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   98    64  60  50  40 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.